Delivery Order SPE2DB20D7059-SPE2DB25FPYU6
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GARDASIL 9 syringes, 0.5 ml each, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,107.19 and an ultimate completion date of May 3, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
The federal contract award is for the delivery of GARDASIL 9 syringes (0.5ML) by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $9,823.42 and a completion date of September 4, 2024. This is a delivery order contract with a firm fixed price. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $6,794.48. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 9, 2024. The contract was not set aside for any specific business type. AmerisourceBergen...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The $5,773.01 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 11, 2024 and was awarded on October 10, 2024. This is a delivery order contract without any set-aside requirements, indicating open competition. AmerisourceBergen holds...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5mL) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a ceiling value of $8,432.30. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a Defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $13,363.82. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of April 19, 2023. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $15,773.30, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award is for the delivery of GARDASIL 9 syringes with a 0.5mL capacity. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $3,494.92 and an ultimate completion date of January 30, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of the GARDASIL 9 SYRINGE 0.5ML vaccine to the Defense Logistics Agency (DLA), a defense agency. The $3,006.56 firm-fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical vaccine product, to the Defense Logistics Agency (DLA). The $10,009.41 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 7, 2025, with a completion date of February 10, 2025. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...